Search
Results: 4
Evaluation of pretreatment ADC values as predictors of treatment response to neoadjuvant chemotherapy in patients with breast cancer - a multicenter study.
Alexey Surov, Maciej Pech, Hans-Jonas Meyer, Almir GV Bitencourt, Hiroshi Fujimoto, Gabrielle C Baxter, Gorane Santamaría, Fiona J Gilbert, Andreas Wienke
Jan 10, 2023
BACKGROUND: Magnetic resonance imaging (MRI) can be used to diagnose breast cancer. Diffusion weighted imaging (DWI) and the apparent diffusion coefficient (ADC) can reflect tumor microstructure in a non-invasive manner. The...
The NeST (Neoadjuvant systemic therapy in breast cancer) study
I. Whitehead, G. W. Irwin, F. Bannon, C. E. Coles, E. Copson, R. I. Cutress, R. V. Dave, M. D. Gardiner, M. Grayson, C. Holcombe, S. Irshad, C. O’Brien, R. L. O’Connell, C. Palmieri, A. M. Shaaban, N. Sharma, J. K. Singh, S. Potter, S. A. McIntosh, Liz Clayton, Ellen Copson, Karina Cox, Tim Crook, Beatrix Elsberger, Ahmed Ghoneima, Sirwan Hadad, Anita Hargreaves, Paul Healy, Adam Heetun, Dan Henderson, Julia Henderson, Natalie Hirst, Fiona Hoar, Mike Hughes, Emma Iddles, Sheeba Irshad, Tracey Irvine, Stacey Jones, Sarantos Kaptanis, Emma MacInnes, Andrew McCanny, Linda McLaughlin, Anthony Neal, Rachel O’Connell, Neill Patani, Belinda Pearce, Mandana Pennick, Simon Pilgrim, Rene Roux, Matthew Rowland, Sunita Saha, Kavita Sharma, Jagdeep Singh, Chiara Sirianni, Brendan Skelly, Rachel Soulsby, Mark Tatterton, Rob Thomas, Medy Tsalic, Raghavan Vidya, Olivia Waker, Lisa Whisker, Ian Whitehead, Janet Woods
Jan 22, 2021
Abstract: Background: Neoadjuvant systemic therapy (NST) is increasingly used in the treatment of breast cancer, yet it is clear that there is significant geographical variation in its use in the UK. This study aimed to examine...
Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models
Reem Bedair, Andrew N Priest, Andrew J Patterson, Mary A McLean, Martin J Graves, Roido Manavaki, Andrew B Gill, Oshaani Abeyakoon, John R Griffiths, Fiona J Gilbert
Dec 06, 2016
Breast carcinoma diffusion-weighted MRI Neoadjuvant treatment quantitative evaluation Tumour biomarkers Adult Aged Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Chemotherapy Adjuvant cyclophosphamide Diffusion Magnetic Resonance Imaging Docetaxel Epirubicin Feasibility Studies Female Fluorouracil Humans Magnetic Resonance Imaging Middle Aged Neoadjuvant Therapy Reproducibility of Results Taxoids
Evaluation of pretreatment ADC values as predictors of treatment response to neoadjuvant chemotherapy in patients with breast cancer - a multicenter study.
Alexey Surov, Maciej Pech, Hans-Jonas Meyer, Almir GV Bitencourt, Hiroshi Fujimoto, Gabrielle C Baxter, Gorane Santamaría, Fiona J Gilbert, Andreas Wienke
Dec 09, 2022
BACKGROUND: Magnetic resonance imaging (MRI) can be used to diagnose breast cancer. Diffusion weighted imaging (DWI) and the apparent diffusion coefficient (ADC) can reflect tumor microstructure in a non-invasive manner. The...